---
title: "Ovarian Cancer Clinical Trials in Tennessee"
description: "Find 385 clinical trials for ovarian cancer near Tennessee. Connect with research centers in your area."
url: "https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/tennessee"
---

# Ovarian Cancer Clinical Trials in Tennessee

Find 385 clinical trials for ovarian cancer near Tennessee. Connect with research centers in your area.

- [All Ovarian Cancer trials nationwide](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer)
- [All trials in Tennessee](https://www.clareohealth.com/clinical-trials/location/tennessee)

Showing 1-20 of 385 trials

### [Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer](https://www.clareohealth.com/clinical-trials/NCT03939481)

Status: ACTIVE_NOT_RECRUITING · NCT03939481 · Antioch, California and 168 others · Sponsor: SWOG Cancer Research Network

This trial studies treatment effects on development of chemotherapy-induced peripheral neuropathy in patients with cancer.

### [Patient Reported Symptoms in Ovarian Cancer (PRECISION)](https://www.clareohealth.com/clinical-trials/NCT01422265)

Status: COMPLETED · NCT01422265 · Goodyear, Arizona and 30 others · Sponsor: Genentech, Inc.

This multicenter, observational, prospective study will include approximately 20 US-based centers, and approximately 142 patients diagnosed with epithelial ovarian cancer, primary…

### [Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers](https://www.clareohealth.com/clinical-trials/NCT05041257)

Status: COMPLETED · Phase: PHASE2 · NCT05041257 · Duarte, California and 34 others · Sponsor: AbbVie

PICCOLO (IMGN853-0419) is a Phase 2 multicenter, open label study designed to evaluate the safety and efficacy of Mirvetuximab Soravtansine in participants with platinum-sensitive…

### [A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck](https://www.clareohealth.com/clinical-trials/NCT01059643)

Status: COMPLETED · Phase: PHASE2 · NCT01059643 · Jonesboro, Arkansas and 17 others · Sponsor: Eli Lilly and Company

The purpose of the study is to estimate the rate of response for patients with ovarian, non-small cell lung, prostate, colorectal, gastroesophageal, and head and neck cancers who a…

### [REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1](https://www.clareohealth.com/clinical-trials/NCT05870748)

Status: TERMINATED · Phase: PHASE2/PHASE3 · NCT05870748 · Tucson, Arizona and 62 others · Sponsor: Sutro Biopharma, Inc.

A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fallopian tube or primary peritone…

### [Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors](https://www.clareohealth.com/clinical-trials/NCT04774952)

Status: COMPLETED · Phase: PHASE1 · NCT04774952 · Irvine, California and 7 others · Sponsor: Revolution Medicines, Inc.

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) profiles of escalating doses of RMC-5552 monotherapy in adult part…

### [A Study LY2228820 for Recurrent Ovarian Cancer](https://www.clareohealth.com/clinical-trials/NCT01663857)

Status: COMPLETED · Phase: PHASE1/PHASE2 · NCT01663857 · Phoenix, Arizona and 29 others · Sponsor: Eli Lilly and Company

A study for women with ovarian cancer that has returned at least 6 months after platinum-based chemotherapy.

### [Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer](https://www.clareohealth.com/clinical-trials/NCT00407563)

Status: COMPLETED · Phase: PHASE2 · NCT00407563 · Little Rock, Arkansas and 10 others · Sponsor: Accelerated Community Oncology Research Network

The purpose of this study is to evaluate the effectiveness and tolerability of the combination of bevacizumab and Abraxane in the treatment of women with epithelial ovarian cancer…

### [TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer](https://www.clareohealth.com/clinical-trials/NCT01204749)

Status: COMPLETED · Phase: PHASE3 · NCT01204749 · Phoenix, Arizona and 224 others · Sponsor: Amgen

The purpose of this study is to determine if treatment with paclitaxel plus AMG 386 is superior to paclitaxel plus placebo in women with recurrent partially platinum sensitive or r…

### [Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules](https://www.clareohealth.com/clinical-trials/NCT01226316)

Status: COMPLETED · Phase: PHASE1 · NCT01226316 · Los Angeles, California and 33 others · Sponsor: AstraZeneca

This study is designed to investigate the safety and tolerability of a new drug, AZD5363, in patients with advanced cancer - and to identify a dose and schedule that can be used in…

### [A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors](https://www.clareohealth.com/clinical-trials/NCT05973487)

Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1 · NCT05973487 · Scottsdale, Arizona and 20 others · Sponsor: TScan Therapeutics, Inc.

TScan Therapeutics is developing cellular therapies across multiple solid tumors in which autologous participant-derived engeneered T cells are engineered to express a T cell recep…

### [Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse](https://www.clareohealth.com/clinical-trials/NCT00849667)

Status: TERMINATED · Phase: PHASE3 · NCT00849667 · Birmingham, Alabama and 374 others · Sponsor: Morphotek

This research is being done to find out if Carboplatin and Taxane works better alone or when given with an experimental drug called MORAb-003(farletuzumab) in subjects with first p…

### [A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies](https://www.clareohealth.com/clinical-trials/NCT04244552)

Status: TERMINATED · Phase: PHASE1 · NCT04244552 · Phoenix, Arizona and 18 others · Sponsor: Atreca, Inc.

ATRC-101-A01 is a Phase 1b, open-label dose escalation and expansion trial of ATRC-101, an engineered fully human immunoglobulin G, subclass 1 (IgG1) antibody derived from a natura…

### [NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer](https://www.clareohealth.com/clinical-trials/NCT03146663)

Status: TERMINATED · Phase: PHASE2 · NCT03146663 · Phoenix, Arizona and 16 others · Sponsor: NuCana plc

This study was designed to evaluate the effect of two dose levels of NUC-1031 (500 mg/m2 and 750mg/m2) in patients with ovarian cancer.

### [Study of Cabozantinib (XL184) in Adults With Advanced Malignancies](https://www.clareohealth.com/clinical-trials/NCT00940225)

Status: COMPLETED · Phase: PHASE2 · NCT00940225 · Scottsdale, Arizona and 46 others · Sponsor: Exelixis

This is a Phase 2 study to evaluate the efficacy and safety of cabozantinib (XL184) in subjects with selected advanced tumor types.

### [Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib](https://www.clareohealth.com/clinical-trials/NCT01831726)

Status: COMPLETED · Phase: PHASE2 · NCT01831726 · Birmingham, Alabama and 48 others · Sponsor: Novartis Pharmaceuticals

The purpose of this signal seeking study was to determine whether treatment with dovitinib (TKI258) demonstrated sufficient efficacy in select pathway-activated solid tumors and/or…

### [Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer](https://www.clareohealth.com/clinical-trials/NCT00262847)

Status: COMPLETED · Phase: PHASE3 · NCT00262847 · Anniston, Alabama and 631 others · Sponsor: National Cancer Institute (NCI)

This randomized phase III trial studies carboplatin, paclitaxel, and bevacizumab to see how well they work compared to carboplatin, paclitaxel, and placebo in treating patients wit…

### [Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies](https://www.clareohealth.com/clinical-trials/NCT03126110)

Status: COMPLETED · Phase: PHASE1/PHASE2 · NCT03126110 · Los Angeles, California and 37 others · Sponsor: Incyte Biosciences International Sàrl

The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or metasta…

### [Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer](https://www.clareohealth.com/clinical-trials/NCT01940172)

Status: COMPLETED · Phase: PHASE1 · NCT01940172 · Fresno, California and 8 others · Sponsor: TetraLogic Pharmaceuticals

This is a dose escalation study in female subjects with relapsed ovarian cancer (including epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer).

### [EP0057 in Combination With Olaparib in Advanced Ovarian Cancer](https://www.clareohealth.com/clinical-trials/NCT04669002)

Status: COMPLETED · Phase: PHASE2 · NCT04669002 · Irvine, California and 20 others · Sponsor: Ellipses Pharma

EP0057-201 is a Phase 2A/B adaptive design study.

## Ovarian Cancer Trials in Other Cities

- [New York](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/new-york)
- [Los Angeles](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/los-angeles)
- [Chicago](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/chicago)
- [Houston](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/houston)
- [Phoenix](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/phoenix)
- [Philadelphia](https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/philadelphia)

## Other Conditions in Tennessee

- [Breast Cancer](https://www.clareohealth.com/clinical-trials/condition/breast-cancer/tennessee)
- [Lung Cancer](https://www.clareohealth.com/clinical-trials/condition/lung-cancer/tennessee)
- [Prostate Cancer](https://www.clareohealth.com/clinical-trials/condition/prostate-cancer/tennessee)
- [Colorectal Cancer](https://www.clareohealth.com/clinical-trials/condition/colorectal-cancer/tennessee)
- [Melanoma](https://www.clareohealth.com/clinical-trials/condition/melanoma/tennessee)
- [Leukemia](https://www.clareohealth.com/clinical-trials/condition/leukemia/tennessee)

Data from [ClinicalTrials.gov](https://clinicaltrials.gov).

---

## Sitemap

This is the Markdown version of https://www.clareohealth.com/clinical-trials/condition/ovarian-cancer/tennessee.

- [Home](https://www.clareohealth.com/index.md)
- [About](https://www.clareohealth.com/about.md)
- [Pricing](https://www.clareohealth.com/pricing.md)
- [For providers](https://www.clareohealth.com/providers.md)
- [FAQ](https://www.clareohealth.com/faq.md)
- [Blog](https://www.clareohealth.com/blog.md)
- [Clinical trials](https://www.clareohealth.com/clinical-trials.md)
- [Developers](https://www.clareohealth.com/developers.md)
- [Privacy policy](https://www.clareohealth.com/legal/privacy-policy.md)
- [Terms of service](https://www.clareohealth.com/legal/terms-of-service.md)
- [Every page](https://www.clareohealth.com/sitemap.md)
- [About this site, for agents](https://www.clareohealth.com/llms.txt)
